Macrophage Reprogramming with Anti-miR223-Loaded Artificial Protocells Enhances In Vivo Cancer Therapeutic Potential. (2022)
Attributed to:
BrisEngBio: From Synthetic to Engineering Biology at Bristol
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1002/advs.202202717
PubMed Identifier: 36314048
Publication URI: http://europepmc.org/abstract/MED/36314048
Type: Journal Article/Review
Volume: 9
Parent Publication: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Issue: 35
ISSN: 2198-3844